Global Modified NSAIDs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Modified NSAIDs market size was valued at US$ 7540 million in 2025 and is forecast to a readjusted size of US$ 12432 million by 2032 with a CAGR of 7.8% during review period.
Modified nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs developed from traditional NSAIDs (such as ibuprofen, indomethacin, and diclofenac) through molecular structure modification, improved formulation processes, or combination therapy strategies to reduce side effects and improve safety and efficacy. The main side effects of traditional NSAIDs are gastrointestinal damage, cardiovascular risk, and kidney impairment. Modified NSAIDs significantly reduce these risks and improve long-term safety through structural or formulation innovations. The product is priced at approximately $5,000 per kg, with global sales of approximately 1.46 million kg.
The upstream sector consists of active pharmaceutical ingredients (COX inhibitors, synthetic intermediates); the midstream sector comprises modified formulation companies (controlled-release tablets, transdermal patches, and combination formulations); and the downstream sector includes hospitals, pharmacies, and the OTC market. Future trends are safety-driven: selective COX-2 inhibitors and novel formulations will gradually replace traditional NSAIDs, especially in the elderly and patients with chronic diseases. Precision medicine and biologics will also become complementary treatment options.
This report is a detailed and comprehensive analysis for global Modified NSAIDs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Modified NSAIDs market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Modified NSAIDs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Modified NSAIDs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Modified NSAIDs market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Modified NSAIDs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Modified NSAIDs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novartis, Bayer, AbbVie, Takeda, Sanofi, GSK, Johnson & Johnson, Teva, Sun Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Modified NSAIDs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Modified NSAIDs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Modified NSAIDs, with price, sales quantity, revenue, and global market share of Modified NSAIDs from 2021 to 2026.
Chapter 3, the Modified NSAIDs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Modified NSAIDs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Modified NSAIDs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Modified NSAIDs.
Chapter 14 and 15, to describe Modified NSAIDs sales channel, distributors, customers, research findings and conclusion.
Modified nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs developed from traditional NSAIDs (such as ibuprofen, indomethacin, and diclofenac) through molecular structure modification, improved formulation processes, or combination therapy strategies to reduce side effects and improve safety and efficacy. The main side effects of traditional NSAIDs are gastrointestinal damage, cardiovascular risk, and kidney impairment. Modified NSAIDs significantly reduce these risks and improve long-term safety through structural or formulation innovations. The product is priced at approximately $5,000 per kg, with global sales of approximately 1.46 million kg.
The upstream sector consists of active pharmaceutical ingredients (COX inhibitors, synthetic intermediates); the midstream sector comprises modified formulation companies (controlled-release tablets, transdermal patches, and combination formulations); and the downstream sector includes hospitals, pharmacies, and the OTC market. Future trends are safety-driven: selective COX-2 inhibitors and novel formulations will gradually replace traditional NSAIDs, especially in the elderly and patients with chronic diseases. Precision medicine and biologics will also become complementary treatment options.
This report is a detailed and comprehensive analysis for global Modified NSAIDs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Modified NSAIDs market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Modified NSAIDs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Modified NSAIDs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Modified NSAIDs market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Modified NSAIDs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Modified NSAIDs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novartis, Bayer, AbbVie, Takeda, Sanofi, GSK, Johnson & Johnson, Teva, Sun Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Modified NSAIDs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- COX-2 Selective Inhibitors
- NO-NSAIDs (Nitric Oxide Releasers)
- Others
- Acute Pain Management
- Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
- Others
- Sustained-Release/Controlled-Release Tablets
- Transdermal Patches, Gels
- Microencapsulated Formulations
- Hospital Clinical Department
- Sports Medicine
- Others
- Pfizer
- Novartis
- Bayer
- AbbVie
- Takeda
- Sanofi
- GSK
- Johnson & Johnson
- Teva
- Sun Pharma
- Cipla
- Dr. Reddy's
- Aurobindo
- Zydus Cadila
- Torrent Pharma
- Viatris
- Apotex
- Hikma
- Jiangsu Hengrui Pharmaceuticals
- Suzhou Homesun Pharmaceutical
- CSPC Pharmaceutical
- Zhejiang Sundoc Pharmaceutical
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Modified NSAIDs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Modified NSAIDs, with price, sales quantity, revenue, and global market share of Modified NSAIDs from 2021 to 2026.
Chapter 3, the Modified NSAIDs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Modified NSAIDs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Modified NSAIDs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Modified NSAIDs.
Chapter 14 and 15, to describe Modified NSAIDs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Modified NSAIDs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 COX-2 Selective Inhibitors
1.3.3 NO-NSAIDs (Nitric Oxide Releasers)
1.3.4 Others
1.4 Market Analysis by Application Scenarios
1.4.1 Overview: Global Modified NSAIDs Consumption Value by Application Scenarios: 2021 Versus 2025 Versus 2032
1.4.2 Acute Pain Management
1.4.3 Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
1.4.4 Others
1.5 Market Analysis by Manufacturing Process
1.5.1 Overview: Global Modified NSAIDs Consumption Value by Manufacturing Process: 2021 Versus 2025 Versus 2032
1.5.2 Sustained-Release/Controlled-Release Tablets
1.5.3 Transdermal Patches, Gels
1.5.4 Microencapsulated Formulations
1.6 Market Analysis by Application
1.6.1 Overview: Global Modified NSAIDs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital Clinical Department
1.6.3 Sports Medicine
1.6.4 Others
1.7 Global Modified NSAIDs Market Size & Forecast
1.7.1 Global Modified NSAIDs Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Modified NSAIDs Sales Quantity (2021-2032)
1.7.3 Global Modified NSAIDs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Modified NSAIDs Product and Services
2.1.4 Pfizer Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Modified NSAIDs Product and Services
2.2.4 Novartis Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Modified NSAIDs Product and Services
2.3.4 Bayer Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bayer Recent Developments/Updates
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Modified NSAIDs Product and Services
2.4.4 AbbVie Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AbbVie Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Modified NSAIDs Product and Services
2.5.4 Takeda Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Takeda Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Modified NSAIDs Product and Services
2.6.4 Sanofi Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sanofi Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Modified NSAIDs Product and Services
2.7.4 GSK Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 GSK Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Modified NSAIDs Product and Services
2.8.4 Johnson & Johnson Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Modified NSAIDs Product and Services
2.9.4 Teva Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Teva Recent Developments/Updates
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Modified NSAIDs Product and Services
2.10.4 Sun Pharma Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Sun Pharma Recent Developments/Updates
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla Modified NSAIDs Product and Services
2.11.4 Cipla Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cipla Recent Developments/Updates
2.12 Dr. Reddy's
2.12.1 Dr. Reddy's Details
2.12.2 Dr. Reddy's Major Business
2.12.3 Dr. Reddy's Modified NSAIDs Product and Services
2.12.4 Dr. Reddy's Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Dr. Reddy's Recent Developments/Updates
2.13 Aurobindo
2.13.1 Aurobindo Details
2.13.2 Aurobindo Major Business
2.13.3 Aurobindo Modified NSAIDs Product and Services
2.13.4 Aurobindo Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Aurobindo Recent Developments/Updates
2.14 Zydus Cadila
2.14.1 Zydus Cadila Details
2.14.2 Zydus Cadila Major Business
2.14.3 Zydus Cadila Modified NSAIDs Product and Services
2.14.4 Zydus Cadila Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Zydus Cadila Recent Developments/Updates
2.15 Torrent Pharma
2.15.1 Torrent Pharma Details
2.15.2 Torrent Pharma Major Business
2.15.3 Torrent Pharma Modified NSAIDs Product and Services
2.15.4 Torrent Pharma Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Torrent Pharma Recent Developments/Updates
2.16 Viatris
2.16.1 Viatris Details
2.16.2 Viatris Major Business
2.16.3 Viatris Modified NSAIDs Product and Services
2.16.4 Viatris Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Viatris Recent Developments/Updates
2.17 Apotex
2.17.1 Apotex Details
2.17.2 Apotex Major Business
2.17.3 Apotex Modified NSAIDs Product and Services
2.17.4 Apotex Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Apotex Recent Developments/Updates
2.18 Hikma
2.18.1 Hikma Details
2.18.2 Hikma Major Business
2.18.3 Hikma Modified NSAIDs Product and Services
2.18.4 Hikma Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Hikma Recent Developments/Updates
2.19 Jiangsu Hengrui Pharmaceuticals
2.19.1 Jiangsu Hengrui Pharmaceuticals Details
2.19.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.19.3 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
2.19.4 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.20 Suzhou Homesun Pharmaceutical
2.20.1 Suzhou Homesun Pharmaceutical Details
2.20.2 Suzhou Homesun Pharmaceutical Major Business
2.20.3 Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
2.20.4 Suzhou Homesun Pharmaceutical Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
2.21 CSPC Pharmaceutical
2.21.1 CSPC Pharmaceutical Details
2.21.2 CSPC Pharmaceutical Major Business
2.21.3 CSPC Pharmaceutical Modified NSAIDs Product and Services
2.21.4 CSPC Pharmaceutical Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 CSPC Pharmaceutical Recent Developments/Updates
2.22 Zhejiang Sundoc Pharmaceutical
2.22.1 Zhejiang Sundoc Pharmaceutical Details
2.22.2 Zhejiang Sundoc Pharmaceutical Major Business
2.22.3 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
2.22.4 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MODIFIED NSAIDS BY MANUFACTURER
3.1 Global Modified NSAIDs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Modified NSAIDs Revenue by Manufacturer (2021-2026)
3.3 Global Modified NSAIDs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Modified NSAIDs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Modified NSAIDs Manufacturer Market Share in 2025
3.4.3 Top 6 Modified NSAIDs Manufacturer Market Share in 2025
3.5 Modified NSAIDs Market: Overall Company Footprint Analysis
3.5.1 Modified NSAIDs Market: Region Footprint
3.5.2 Modified NSAIDs Market: Company Product Type Footprint
3.5.3 Modified NSAIDs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Modified NSAIDs Market Size by Region
4.1.1 Global Modified NSAIDs Sales Quantity by Region (2021-2032)
4.1.2 Global Modified NSAIDs Consumption Value by Region (2021-2032)
4.1.3 Global Modified NSAIDs Average Price by Region (2021-2032)
4.2 North America Modified NSAIDs Consumption Value (2021-2032)
4.3 Europe Modified NSAIDs Consumption Value (2021-2032)
4.4 Asia-Pacific Modified NSAIDs Consumption Value (2021-2032)
4.5 South America Modified NSAIDs Consumption Value (2021-2032)
4.6 Middle East & Africa Modified NSAIDs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Modified NSAIDs Sales Quantity by Type (2021-2032)
5.2 Global Modified NSAIDs Consumption Value by Type (2021-2032)
5.3 Global Modified NSAIDs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Modified NSAIDs Sales Quantity by Application (2021-2032)
6.2 Global Modified NSAIDs Consumption Value by Application (2021-2032)
6.3 Global Modified NSAIDs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Modified NSAIDs Sales Quantity by Type (2021-2032)
7.2 North America Modified NSAIDs Sales Quantity by Application (2021-2032)
7.3 North America Modified NSAIDs Market Size by Country
7.3.1 North America Modified NSAIDs Sales Quantity by Country (2021-2032)
7.3.2 North America Modified NSAIDs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Modified NSAIDs Sales Quantity by Type (2021-2032)
8.2 Europe Modified NSAIDs Sales Quantity by Application (2021-2032)
8.3 Europe Modified NSAIDs Market Size by Country
8.3.1 Europe Modified NSAIDs Sales Quantity by Country (2021-2032)
8.3.2 Europe Modified NSAIDs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Modified NSAIDs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Modified NSAIDs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Modified NSAIDs Market Size by Region
9.3.1 Asia-Pacific Modified NSAIDs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Modified NSAIDs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Modified NSAIDs Sales Quantity by Type (2021-2032)
10.2 South America Modified NSAIDs Sales Quantity by Application (2021-2032)
10.3 South America Modified NSAIDs Market Size by Country
10.3.1 South America Modified NSAIDs Sales Quantity by Country (2021-2032)
10.3.2 South America Modified NSAIDs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Modified NSAIDs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Modified NSAIDs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Modified NSAIDs Market Size by Country
11.3.1 Middle East & Africa Modified NSAIDs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Modified NSAIDs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Modified NSAIDs Market Drivers
12.2 Modified NSAIDs Market Restraints
12.3 Modified NSAIDs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Modified NSAIDs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Modified NSAIDs
13.3 Modified NSAIDs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Modified NSAIDs Typical Distributors
14.3 Modified NSAIDs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Modified NSAIDs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 COX-2 Selective Inhibitors
1.3.3 NO-NSAIDs (Nitric Oxide Releasers)
1.3.4 Others
1.4 Market Analysis by Application Scenarios
1.4.1 Overview: Global Modified NSAIDs Consumption Value by Application Scenarios: 2021 Versus 2025 Versus 2032
1.4.2 Acute Pain Management
1.4.3 Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
1.4.4 Others
1.5 Market Analysis by Manufacturing Process
1.5.1 Overview: Global Modified NSAIDs Consumption Value by Manufacturing Process: 2021 Versus 2025 Versus 2032
1.5.2 Sustained-Release/Controlled-Release Tablets
1.5.3 Transdermal Patches, Gels
1.5.4 Microencapsulated Formulations
1.6 Market Analysis by Application
1.6.1 Overview: Global Modified NSAIDs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital Clinical Department
1.6.3 Sports Medicine
1.6.4 Others
1.7 Global Modified NSAIDs Market Size & Forecast
1.7.1 Global Modified NSAIDs Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Modified NSAIDs Sales Quantity (2021-2032)
1.7.3 Global Modified NSAIDs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Modified NSAIDs Product and Services
2.1.4 Pfizer Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Modified NSAIDs Product and Services
2.2.4 Novartis Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Modified NSAIDs Product and Services
2.3.4 Bayer Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bayer Recent Developments/Updates
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Modified NSAIDs Product and Services
2.4.4 AbbVie Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AbbVie Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Modified NSAIDs Product and Services
2.5.4 Takeda Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Takeda Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Modified NSAIDs Product and Services
2.6.4 Sanofi Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sanofi Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Modified NSAIDs Product and Services
2.7.4 GSK Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 GSK Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Modified NSAIDs Product and Services
2.8.4 Johnson & Johnson Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Modified NSAIDs Product and Services
2.9.4 Teva Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Teva Recent Developments/Updates
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Modified NSAIDs Product and Services
2.10.4 Sun Pharma Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Sun Pharma Recent Developments/Updates
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla Modified NSAIDs Product and Services
2.11.4 Cipla Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cipla Recent Developments/Updates
2.12 Dr. Reddy's
2.12.1 Dr. Reddy's Details
2.12.2 Dr. Reddy's Major Business
2.12.3 Dr. Reddy's Modified NSAIDs Product and Services
2.12.4 Dr. Reddy's Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Dr. Reddy's Recent Developments/Updates
2.13 Aurobindo
2.13.1 Aurobindo Details
2.13.2 Aurobindo Major Business
2.13.3 Aurobindo Modified NSAIDs Product and Services
2.13.4 Aurobindo Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Aurobindo Recent Developments/Updates
2.14 Zydus Cadila
2.14.1 Zydus Cadila Details
2.14.2 Zydus Cadila Major Business
2.14.3 Zydus Cadila Modified NSAIDs Product and Services
2.14.4 Zydus Cadila Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Zydus Cadila Recent Developments/Updates
2.15 Torrent Pharma
2.15.1 Torrent Pharma Details
2.15.2 Torrent Pharma Major Business
2.15.3 Torrent Pharma Modified NSAIDs Product and Services
2.15.4 Torrent Pharma Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Torrent Pharma Recent Developments/Updates
2.16 Viatris
2.16.1 Viatris Details
2.16.2 Viatris Major Business
2.16.3 Viatris Modified NSAIDs Product and Services
2.16.4 Viatris Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Viatris Recent Developments/Updates
2.17 Apotex
2.17.1 Apotex Details
2.17.2 Apotex Major Business
2.17.3 Apotex Modified NSAIDs Product and Services
2.17.4 Apotex Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Apotex Recent Developments/Updates
2.18 Hikma
2.18.1 Hikma Details
2.18.2 Hikma Major Business
2.18.3 Hikma Modified NSAIDs Product and Services
2.18.4 Hikma Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Hikma Recent Developments/Updates
2.19 Jiangsu Hengrui Pharmaceuticals
2.19.1 Jiangsu Hengrui Pharmaceuticals Details
2.19.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.19.3 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
2.19.4 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.20 Suzhou Homesun Pharmaceutical
2.20.1 Suzhou Homesun Pharmaceutical Details
2.20.2 Suzhou Homesun Pharmaceutical Major Business
2.20.3 Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
2.20.4 Suzhou Homesun Pharmaceutical Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
2.21 CSPC Pharmaceutical
2.21.1 CSPC Pharmaceutical Details
2.21.2 CSPC Pharmaceutical Major Business
2.21.3 CSPC Pharmaceutical Modified NSAIDs Product and Services
2.21.4 CSPC Pharmaceutical Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 CSPC Pharmaceutical Recent Developments/Updates
2.22 Zhejiang Sundoc Pharmaceutical
2.22.1 Zhejiang Sundoc Pharmaceutical Details
2.22.2 Zhejiang Sundoc Pharmaceutical Major Business
2.22.3 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
2.22.4 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MODIFIED NSAIDS BY MANUFACTURER
3.1 Global Modified NSAIDs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Modified NSAIDs Revenue by Manufacturer (2021-2026)
3.3 Global Modified NSAIDs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Modified NSAIDs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Modified NSAIDs Manufacturer Market Share in 2025
3.4.3 Top 6 Modified NSAIDs Manufacturer Market Share in 2025
3.5 Modified NSAIDs Market: Overall Company Footprint Analysis
3.5.1 Modified NSAIDs Market: Region Footprint
3.5.2 Modified NSAIDs Market: Company Product Type Footprint
3.5.3 Modified NSAIDs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Modified NSAIDs Market Size by Region
4.1.1 Global Modified NSAIDs Sales Quantity by Region (2021-2032)
4.1.2 Global Modified NSAIDs Consumption Value by Region (2021-2032)
4.1.3 Global Modified NSAIDs Average Price by Region (2021-2032)
4.2 North America Modified NSAIDs Consumption Value (2021-2032)
4.3 Europe Modified NSAIDs Consumption Value (2021-2032)
4.4 Asia-Pacific Modified NSAIDs Consumption Value (2021-2032)
4.5 South America Modified NSAIDs Consumption Value (2021-2032)
4.6 Middle East & Africa Modified NSAIDs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Modified NSAIDs Sales Quantity by Type (2021-2032)
5.2 Global Modified NSAIDs Consumption Value by Type (2021-2032)
5.3 Global Modified NSAIDs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Modified NSAIDs Sales Quantity by Application (2021-2032)
6.2 Global Modified NSAIDs Consumption Value by Application (2021-2032)
6.3 Global Modified NSAIDs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Modified NSAIDs Sales Quantity by Type (2021-2032)
7.2 North America Modified NSAIDs Sales Quantity by Application (2021-2032)
7.3 North America Modified NSAIDs Market Size by Country
7.3.1 North America Modified NSAIDs Sales Quantity by Country (2021-2032)
7.3.2 North America Modified NSAIDs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Modified NSAIDs Sales Quantity by Type (2021-2032)
8.2 Europe Modified NSAIDs Sales Quantity by Application (2021-2032)
8.3 Europe Modified NSAIDs Market Size by Country
8.3.1 Europe Modified NSAIDs Sales Quantity by Country (2021-2032)
8.3.2 Europe Modified NSAIDs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Modified NSAIDs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Modified NSAIDs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Modified NSAIDs Market Size by Region
9.3.1 Asia-Pacific Modified NSAIDs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Modified NSAIDs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Modified NSAIDs Sales Quantity by Type (2021-2032)
10.2 South America Modified NSAIDs Sales Quantity by Application (2021-2032)
10.3 South America Modified NSAIDs Market Size by Country
10.3.1 South America Modified NSAIDs Sales Quantity by Country (2021-2032)
10.3.2 South America Modified NSAIDs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Modified NSAIDs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Modified NSAIDs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Modified NSAIDs Market Size by Country
11.3.1 Middle East & Africa Modified NSAIDs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Modified NSAIDs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Modified NSAIDs Market Drivers
12.2 Modified NSAIDs Market Restraints
12.3 Modified NSAIDs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Modified NSAIDs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Modified NSAIDs
13.3 Modified NSAIDs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Modified NSAIDs Typical Distributors
14.3 Modified NSAIDs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Modified NSAIDs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Modified NSAIDs Consumption Value by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Table 3. Global Modified NSAIDs Consumption Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 4. Global Modified NSAIDs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Pfizer Basic Information, Manufacturing Base and Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Modified NSAIDs Product and Services
Table 8. Pfizer Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Pfizer Recent Developments/Updates
Table 10. Novartis Basic Information, Manufacturing Base and Competitors
Table 11. Novartis Major Business
Table 12. Novartis Modified NSAIDs Product and Services
Table 13. Novartis Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Novartis Recent Developments/Updates
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Modified NSAIDs Product and Services
Table 18. Bayer Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bayer Recent Developments/Updates
Table 20. AbbVie Basic Information, Manufacturing Base and Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie Modified NSAIDs Product and Services
Table 23. AbbVie Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. AbbVie Recent Developments/Updates
Table 25. Takeda Basic Information, Manufacturing Base and Competitors
Table 26. Takeda Major Business
Table 27. Takeda Modified NSAIDs Product and Services
Table 28. Takeda Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Takeda Recent Developments/Updates
Table 30. Sanofi Basic Information, Manufacturing Base and Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Modified NSAIDs Product and Services
Table 33. Sanofi Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Sanofi Recent Developments/Updates
Table 35. GSK Basic Information, Manufacturing Base and Competitors
Table 36. GSK Major Business
Table 37. GSK Modified NSAIDs Product and Services
Table 38. GSK Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. GSK Recent Developments/Updates
Table 40. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 41. Johnson & Johnson Major Business
Table 42. Johnson & Johnson Modified NSAIDs Product and Services
Table 43. Johnson & Johnson Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Johnson & Johnson Recent Developments/Updates
Table 45. Teva Basic Information, Manufacturing Base and Competitors
Table 46. Teva Major Business
Table 47. Teva Modified NSAIDs Product and Services
Table 48. Teva Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Teva Recent Developments/Updates
Table 50. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 51. Sun Pharma Major Business
Table 52. Sun Pharma Modified NSAIDs Product and Services
Table 53. Sun Pharma Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Sun Pharma Recent Developments/Updates
Table 55. Cipla Basic Information, Manufacturing Base and Competitors
Table 56. Cipla Major Business
Table 57. Cipla Modified NSAIDs Product and Services
Table 58. Cipla Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Cipla Recent Developments/Updates
Table 60. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 61. Dr. Reddy's Major Business
Table 62. Dr. Reddy's Modified NSAIDs Product and Services
Table 63. Dr. Reddy's Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Dr. Reddy's Recent Developments/Updates
Table 65. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 66. Aurobindo Major Business
Table 67. Aurobindo Modified NSAIDs Product and Services
Table 68. Aurobindo Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Aurobindo Recent Developments/Updates
Table 70. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 71. Zydus Cadila Major Business
Table 72. Zydus Cadila Modified NSAIDs Product and Services
Table 73. Zydus Cadila Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Zydus Cadila Recent Developments/Updates
Table 75. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Torrent Pharma Major Business
Table 77. Torrent Pharma Modified NSAIDs Product and Services
Table 78. Torrent Pharma Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Torrent Pharma Recent Developments/Updates
Table 80. Viatris Basic Information, Manufacturing Base and Competitors
Table 81. Viatris Major Business
Table 82. Viatris Modified NSAIDs Product and Services
Table 83. Viatris Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Viatris Recent Developments/Updates
Table 85. Apotex Basic Information, Manufacturing Base and Competitors
Table 86. Apotex Major Business
Table 87. Apotex Modified NSAIDs Product and Services
Table 88. Apotex Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Apotex Recent Developments/Updates
Table 90. Hikma Basic Information, Manufacturing Base and Competitors
Table 91. Hikma Major Business
Table 92. Hikma Modified NSAIDs Product and Services
Table 93. Hikma Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Hikma Recent Developments/Updates
Table 95. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. Jiangsu Hengrui Pharmaceuticals Major Business
Table 97. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
Table 98. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 100. Suzhou Homesun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 101. Suzhou Homesun Pharmaceutical Major Business
Table 102. Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
Table 103. Suzhou Homesun Pharmaceutical Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Suzhou Homesun Pharmaceutical Recent Developments/Updates
Table 105. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 106. CSPC Pharmaceutical Major Business
Table 107. CSPC Pharmaceutical Modified NSAIDs Product and Services
Table 108. CSPC Pharmaceutical Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. CSPC Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Sundoc Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 111. Zhejiang Sundoc Pharmaceutical Major Business
Table 112. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
Table 113. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
Table 115. Global Modified NSAIDs Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 116. Global Modified NSAIDs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 117. Global Modified NSAIDs Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 118. Market Position of Manufacturers in Modified NSAIDs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 119. Head Office and Modified NSAIDs Production Site of Key Manufacturer
Table 120. Modified NSAIDs Market: Company Product Type Footprint
Table 121. Modified NSAIDs Market: Company Product Application Footprint
Table 122. Modified NSAIDs New Market Entrants and Barriers to Market Entry
Table 123. Modified NSAIDs Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Modified NSAIDs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 125. Global Modified NSAIDs Sales Quantity by Region (2021-2026) & (Tons)
Table 126. Global Modified NSAIDs Sales Quantity by Region (2027-2032) & (Tons)
Table 127. Global Modified NSAIDs Consumption Value by Region (2021-2026) & (USD Million)
Table 128. Global Modified NSAIDs Consumption Value by Region (2027-2032) & (USD Million)
Table 129. Global Modified NSAIDs Average Price by Region (2021-2026) & (US$/kg)
Table 130. Global Modified NSAIDs Average Price by Region (2027-2032) & (US$/kg)
Table 131. Global Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 132. Global Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 133. Global Modified NSAIDs Consumption Value by Type (2021-2026) & (USD Million)
Table 134. Global Modified NSAIDs Consumption Value by Type (2027-2032) & (USD Million)
Table 135. Global Modified NSAIDs Average Price by Type (2021-2026) & (US$/kg)
Table 136. Global Modified NSAIDs Average Price by Type (2027-2032) & (US$/kg)
Table 137. Global Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 138. Global Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 139. Global Modified NSAIDs Consumption Value by Application (2021-2026) & (USD Million)
Table 140. Global Modified NSAIDs Consumption Value by Application (2027-2032) & (USD Million)
Table 141. Global Modified NSAIDs Average Price by Application (2021-2026) & (US$/kg)
Table 142. Global Modified NSAIDs Average Price by Application (2027-2032) & (US$/kg)
Table 143. North America Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 144. North America Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 145. North America Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 146. North America Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 147. North America Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 148. North America Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 149. North America Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 150. North America Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 151. Europe Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 152. Europe Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 153. Europe Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 154. Europe Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 155. Europe Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 156. Europe Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 157. Europe Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 158. Europe Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 159. Asia-Pacific Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 160. Asia-Pacific Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 161. Asia-Pacific Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 162. Asia-Pacific Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 163. Asia-Pacific Modified NSAIDs Sales Quantity by Region (2021-2026) & (Tons)
Table 164. Asia-Pacific Modified NSAIDs Sales Quantity by Region (2027-2032) & (Tons)
Table 165. Asia-Pacific Modified NSAIDs Consumption Value by Region (2021-2026) & (USD Million)
Table 166. Asia-Pacific Modified NSAIDs Consumption Value by Region (2027-2032) & (USD Million)
Table 167. South America Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 168. South America Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 169. South America Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 170. South America Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 171. South America Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 172. South America Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 173. South America Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 174. South America Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 175. Middle East & Africa Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 176. Middle East & Africa Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 177. Middle East & Africa Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 178. Middle East & Africa Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 179. Middle East & Africa Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 180. Middle East & Africa Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 181. Middle East & Africa Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 182. Middle East & Africa Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 183. Modified NSAIDs Raw Material
Table 184. Key Manufacturers of Modified NSAIDs Raw Materials
Table 185. Modified NSAIDs Typical Distributors
Table 186. Modified NSAIDs Typical Customers
Table 1. Global Modified NSAIDs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Modified NSAIDs Consumption Value by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Table 3. Global Modified NSAIDs Consumption Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 4. Global Modified NSAIDs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Pfizer Basic Information, Manufacturing Base and Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Modified NSAIDs Product and Services
Table 8. Pfizer Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Pfizer Recent Developments/Updates
Table 10. Novartis Basic Information, Manufacturing Base and Competitors
Table 11. Novartis Major Business
Table 12. Novartis Modified NSAIDs Product and Services
Table 13. Novartis Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Novartis Recent Developments/Updates
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Modified NSAIDs Product and Services
Table 18. Bayer Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bayer Recent Developments/Updates
Table 20. AbbVie Basic Information, Manufacturing Base and Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie Modified NSAIDs Product and Services
Table 23. AbbVie Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. AbbVie Recent Developments/Updates
Table 25. Takeda Basic Information, Manufacturing Base and Competitors
Table 26. Takeda Major Business
Table 27. Takeda Modified NSAIDs Product and Services
Table 28. Takeda Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Takeda Recent Developments/Updates
Table 30. Sanofi Basic Information, Manufacturing Base and Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Modified NSAIDs Product and Services
Table 33. Sanofi Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Sanofi Recent Developments/Updates
Table 35. GSK Basic Information, Manufacturing Base and Competitors
Table 36. GSK Major Business
Table 37. GSK Modified NSAIDs Product and Services
Table 38. GSK Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. GSK Recent Developments/Updates
Table 40. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 41. Johnson & Johnson Major Business
Table 42. Johnson & Johnson Modified NSAIDs Product and Services
Table 43. Johnson & Johnson Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Johnson & Johnson Recent Developments/Updates
Table 45. Teva Basic Information, Manufacturing Base and Competitors
Table 46. Teva Major Business
Table 47. Teva Modified NSAIDs Product and Services
Table 48. Teva Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Teva Recent Developments/Updates
Table 50. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 51. Sun Pharma Major Business
Table 52. Sun Pharma Modified NSAIDs Product and Services
Table 53. Sun Pharma Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Sun Pharma Recent Developments/Updates
Table 55. Cipla Basic Information, Manufacturing Base and Competitors
Table 56. Cipla Major Business
Table 57. Cipla Modified NSAIDs Product and Services
Table 58. Cipla Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Cipla Recent Developments/Updates
Table 60. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 61. Dr. Reddy's Major Business
Table 62. Dr. Reddy's Modified NSAIDs Product and Services
Table 63. Dr. Reddy's Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Dr. Reddy's Recent Developments/Updates
Table 65. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 66. Aurobindo Major Business
Table 67. Aurobindo Modified NSAIDs Product and Services
Table 68. Aurobindo Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Aurobindo Recent Developments/Updates
Table 70. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 71. Zydus Cadila Major Business
Table 72. Zydus Cadila Modified NSAIDs Product and Services
Table 73. Zydus Cadila Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Zydus Cadila Recent Developments/Updates
Table 75. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Torrent Pharma Major Business
Table 77. Torrent Pharma Modified NSAIDs Product and Services
Table 78. Torrent Pharma Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Torrent Pharma Recent Developments/Updates
Table 80. Viatris Basic Information, Manufacturing Base and Competitors
Table 81. Viatris Major Business
Table 82. Viatris Modified NSAIDs Product and Services
Table 83. Viatris Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Viatris Recent Developments/Updates
Table 85. Apotex Basic Information, Manufacturing Base and Competitors
Table 86. Apotex Major Business
Table 87. Apotex Modified NSAIDs Product and Services
Table 88. Apotex Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Apotex Recent Developments/Updates
Table 90. Hikma Basic Information, Manufacturing Base and Competitors
Table 91. Hikma Major Business
Table 92. Hikma Modified NSAIDs Product and Services
Table 93. Hikma Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Hikma Recent Developments/Updates
Table 95. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. Jiangsu Hengrui Pharmaceuticals Major Business
Table 97. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
Table 98. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 100. Suzhou Homesun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 101. Suzhou Homesun Pharmaceutical Major Business
Table 102. Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
Table 103. Suzhou Homesun Pharmaceutical Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Suzhou Homesun Pharmaceutical Recent Developments/Updates
Table 105. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 106. CSPC Pharmaceutical Major Business
Table 107. CSPC Pharmaceutical Modified NSAIDs Product and Services
Table 108. CSPC Pharmaceutical Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. CSPC Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Sundoc Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 111. Zhejiang Sundoc Pharmaceutical Major Business
Table 112. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
Table 113. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
Table 115. Global Modified NSAIDs Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 116. Global Modified NSAIDs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 117. Global Modified NSAIDs Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 118. Market Position of Manufacturers in Modified NSAIDs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 119. Head Office and Modified NSAIDs Production Site of Key Manufacturer
Table 120. Modified NSAIDs Market: Company Product Type Footprint
Table 121. Modified NSAIDs Market: Company Product Application Footprint
Table 122. Modified NSAIDs New Market Entrants and Barriers to Market Entry
Table 123. Modified NSAIDs Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Modified NSAIDs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 125. Global Modified NSAIDs Sales Quantity by Region (2021-2026) & (Tons)
Table 126. Global Modified NSAIDs Sales Quantity by Region (2027-2032) & (Tons)
Table 127. Global Modified NSAIDs Consumption Value by Region (2021-2026) & (USD Million)
Table 128. Global Modified NSAIDs Consumption Value by Region (2027-2032) & (USD Million)
Table 129. Global Modified NSAIDs Average Price by Region (2021-2026) & (US$/kg)
Table 130. Global Modified NSAIDs Average Price by Region (2027-2032) & (US$/kg)
Table 131. Global Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 132. Global Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 133. Global Modified NSAIDs Consumption Value by Type (2021-2026) & (USD Million)
Table 134. Global Modified NSAIDs Consumption Value by Type (2027-2032) & (USD Million)
Table 135. Global Modified NSAIDs Average Price by Type (2021-2026) & (US$/kg)
Table 136. Global Modified NSAIDs Average Price by Type (2027-2032) & (US$/kg)
Table 137. Global Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 138. Global Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 139. Global Modified NSAIDs Consumption Value by Application (2021-2026) & (USD Million)
Table 140. Global Modified NSAIDs Consumption Value by Application (2027-2032) & (USD Million)
Table 141. Global Modified NSAIDs Average Price by Application (2021-2026) & (US$/kg)
Table 142. Global Modified NSAIDs Average Price by Application (2027-2032) & (US$/kg)
Table 143. North America Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 144. North America Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 145. North America Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 146. North America Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 147. North America Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 148. North America Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 149. North America Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 150. North America Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 151. Europe Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 152. Europe Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 153. Europe Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 154. Europe Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 155. Europe Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 156. Europe Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 157. Europe Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 158. Europe Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 159. Asia-Pacific Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 160. Asia-Pacific Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 161. Asia-Pacific Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 162. Asia-Pacific Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 163. Asia-Pacific Modified NSAIDs Sales Quantity by Region (2021-2026) & (Tons)
Table 164. Asia-Pacific Modified NSAIDs Sales Quantity by Region (2027-2032) & (Tons)
Table 165. Asia-Pacific Modified NSAIDs Consumption Value by Region (2021-2026) & (USD Million)
Table 166. Asia-Pacific Modified NSAIDs Consumption Value by Region (2027-2032) & (USD Million)
Table 167. South America Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 168. South America Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 169. South America Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 170. South America Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 171. South America Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 172. South America Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 173. South America Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 174. South America Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 175. Middle East & Africa Modified NSAIDs Sales Quantity by Type (2021-2026) & (Tons)
Table 176. Middle East & Africa Modified NSAIDs Sales Quantity by Type (2027-2032) & (Tons)
Table 177. Middle East & Africa Modified NSAIDs Sales Quantity by Application (2021-2026) & (Tons)
Table 178. Middle East & Africa Modified NSAIDs Sales Quantity by Application (2027-2032) & (Tons)
Table 179. Middle East & Africa Modified NSAIDs Sales Quantity by Country (2021-2026) & (Tons)
Table 180. Middle East & Africa Modified NSAIDs Sales Quantity by Country (2027-2032) & (Tons)
Table 181. Middle East & Africa Modified NSAIDs Consumption Value by Country (2021-2026) & (USD Million)
Table 182. Middle East & Africa Modified NSAIDs Consumption Value by Country (2027-2032) & (USD Million)
Table 183. Modified NSAIDs Raw Material
Table 184. Key Manufacturers of Modified NSAIDs Raw Materials
Table 185. Modified NSAIDs Typical Distributors
Table 186. Modified NSAIDs Typical Customers
LIST OF FIGURES
Figure 1. Modified NSAIDs Picture
Figure 2. Global Modified NSAIDs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Modified NSAIDs Revenue Market Share by Type in 2025
Figure 4. COX-2 Selective Inhibitors Examples
Figure 5. NO-NSAIDs (Nitric Oxide Releasers) Examples
Figure 6. Others Examples
Figure 7. Global Modified NSAIDs Revenue by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Modified NSAIDs Revenue Market Share by Application Scenarios in 2025
Figure 9. Acute Pain Management Examples
Figure 10. Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis) Examples
Figure 11. Others Examples
Figure 12. Global Modified NSAIDs Revenue by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Modified NSAIDs Revenue Market Share by Manufacturing Process in 2025
Figure 14. Sustained-Release/Controlled-ReleaseTablets Examples
Figure 15. Transdermal Patches, Gels Examples
Figure 16. Microencapsulated Formulations Examples
Figure 17. Global Modified NSAIDs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Modified NSAIDs Revenue Market Share by Application in 2025
Figure 19. Hospital Clinical Department Examples
Figure 20. Sports Medicine Examples
Figure 21. Others Examples
Figure 22. Global Modified NSAIDs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Modified NSAIDs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Modified NSAIDs Sales Quantity (2021-2032) & (Tons)
Figure 25. Global Modified NSAIDs Price (2021-2032) & (US$/kg)
Figure 26. Global Modified NSAIDs Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Modified NSAIDs Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Modified NSAIDs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Modified NSAIDs Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Modified NSAIDs Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Modified NSAIDs Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Modified NSAIDs Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Modified NSAIDs Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Modified NSAIDs Average Price by Type (2021-2032) & (US$/kg)
Figure 41. Global Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Modified NSAIDs Revenue Market Share by Application (2021-2032)
Figure 43. Global Modified NSAIDs Average Price by Application (2021-2032) & (US$/kg)
Figure 44. North America Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 56. France Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Modified NSAIDs Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Modified NSAIDs Consumption Value Market Share by Region (2021-2032)
Figure 64. China Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 67. India Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 84. Modified NSAIDs Market Drivers
Figure 85. Modified NSAIDs Market Restraints
Figure 86. Modified NSAIDs Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Modified NSAIDs in 2025
Figure 89. Manufacturing Process Analysis of Modified NSAIDs
Figure 90. Modified NSAIDs Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
Figure 1. Modified NSAIDs Picture
Figure 2. Global Modified NSAIDs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Modified NSAIDs Revenue Market Share by Type in 2025
Figure 4. COX-2 Selective Inhibitors Examples
Figure 5. NO-NSAIDs (Nitric Oxide Releasers) Examples
Figure 6. Others Examples
Figure 7. Global Modified NSAIDs Revenue by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Modified NSAIDs Revenue Market Share by Application Scenarios in 2025
Figure 9. Acute Pain Management Examples
Figure 10. Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis) Examples
Figure 11. Others Examples
Figure 12. Global Modified NSAIDs Revenue by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Modified NSAIDs Revenue Market Share by Manufacturing Process in 2025
Figure 14. Sustained-Release/Controlled-ReleaseTablets Examples
Figure 15. Transdermal Patches, Gels Examples
Figure 16. Microencapsulated Formulations Examples
Figure 17. Global Modified NSAIDs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Modified NSAIDs Revenue Market Share by Application in 2025
Figure 19. Hospital Clinical Department Examples
Figure 20. Sports Medicine Examples
Figure 21. Others Examples
Figure 22. Global Modified NSAIDs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Modified NSAIDs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Modified NSAIDs Sales Quantity (2021-2032) & (Tons)
Figure 25. Global Modified NSAIDs Price (2021-2032) & (US$/kg)
Figure 26. Global Modified NSAIDs Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Modified NSAIDs Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Modified NSAIDs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Modified NSAIDs Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Modified NSAIDs Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Modified NSAIDs Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Modified NSAIDs Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Modified NSAIDs Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Modified NSAIDs Average Price by Type (2021-2032) & (US$/kg)
Figure 41. Global Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Modified NSAIDs Revenue Market Share by Application (2021-2032)
Figure 43. Global Modified NSAIDs Average Price by Application (2021-2032) & (US$/kg)
Figure 44. North America Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 56. France Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Modified NSAIDs Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Modified NSAIDs Consumption Value Market Share by Region (2021-2032)
Figure 64. China Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 67. India Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Modified NSAIDs Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Modified NSAIDs Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Modified NSAIDs Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Modified NSAIDs Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Modified NSAIDs Consumption Value (2021-2032) & (USD Million)
Figure 84. Modified NSAIDs Market Drivers
Figure 85. Modified NSAIDs Market Restraints
Figure 86. Modified NSAIDs Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Modified NSAIDs in 2025
Figure 89. Manufacturing Process Analysis of Modified NSAIDs
Figure 90. Modified NSAIDs Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
